Skip to main content

Anixa Biosciences, Inc. (ANIX)

NASDAQ: ANIX · IEX Real-Time Price · USD
4.26 -0.08 (-1.84%)
Oct 25, 2021 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is November - October.
Year2020201920182017201620152014201320122011
Revenue
00.251.110.360.39.263.670.390.941
Revenue Growth
--77.53%206.90%20.83%-96.76%152.36%843.12%-58.63%-6.30%-
Cost of Revenue
00.170.770.10.223.651.990.3200.03
Gross Profit
00.080.340.260.085.611.680.070.940.97
Selling, General & Admin
5.65.666.914.412.715.516.417.992.862.87
Research & Development
4.385.476.811.61.560.71002.213.12
Other Operating Expenses
0.150.840.910.330.330.330.31000
Operating Expenses
10.1311.9714.636.334.596.556.727.995.076
Operating Income
-10.13-11.89-14.29-6.08-4.51-0.94-5.04-7.92-4.13-5.03
Interest Expense / Income
0000.50.520.451.261.110.010
Other Expense / Income
-0.11-0.24-0.29-1.57-0.01-0.023.31.050.111.75
Pretax Income
-10.02-11.65-14-5.01-5.02-1.38-9.61-10.08-4.25-6.78
Income Tax
0000000000.6
Net Income
-10.02-11.65-14-5.01-5.02-1.38-9.61-10.08-4.25-7.38
Preferred Dividends
0002.01000000
Net Income Common
-10.02-11.65-14-7.02-5.02-1.38-9.61-10.08-4.25-7.38
Shares Outstanding (Basic)
22201812999877
Shares Outstanding (Diluted)
22201812999877
Shares Change
12.33%12.29%44.49%39.57%-0.24%0.57%10.74%8.24%8.88%-
EPS (Basic)
-0.45-0.59-0.79-0.58-0.57-0.16-1.10-1.25-0.50-1.00
EPS (Diluted)
-0.45-0.59-0.79-0.58-0.57-0.16-1.10-1.25-0.50-1.00
Free Cash Flow Per Share
-0.28-0.25-0.24-0.31-0.400.15-0.27-0.41-0.43-0.11
Gross Margin
-33.50%30.93%71.16%27.53%60.58%45.79%18.57%100.00%96.60%
Operating Margin
--4756.00%-1284.41%-1676.02%-1503.00%-10.21%-137.54%-2036.17%-439.84%-501.23%
Profit Margin
--4658.82%-1258.07%-1381.79%-1672.14%-14.90%-261.94%-2592.28%-452.42%-735.46%
Free Cash Flow Margin
--1966.75%-387.58%-1043.28%-1176.07%14.14%-65.06%-819.54%-334.12%-72.27%
Effective Tax Rate
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-8.85%
EBITDA
-9.93-11.6-13.98-4.47-4.46-0.91-8.34-8.97-4.25-6.78
EBITDA Margin
--4639.80%-1256.41%-1231.81%-1487.72%-9.88%-227.49%-2306.95%-451.61%-675.65%
EBIT
-10.02-11.65-14-4.51-4.5-0.93-8.34-8.97-4.25-6.78
EBIT Margin
--4658.82%-1258.07%-1243.73%-1498.83%-10.02%-227.49%-2306.95%-451.61%-675.65%
Showing 10 of 25 years
15 more years are available
Start Free Trial
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).